| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | U01HG013781 | The VA Genomics Learning Health System: Implementing genomic medicine across diverse veteran communities | 000 | 1 | NIH | 11/12/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $5,060,385 ) |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01AG081809 | Sleep-dependent mechanisms of improving cerebral blood flow and reducing Alzheimer's disease progression by photobiomodulation with near-infrared light | 000 | 2 | NIH | 1/29/2024 | $643,637 |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01AG081287 | PREVENTABLE Frailty Ancillary Study | 000 | 1 | NIH | 2/15/2024 | $1,333,801 |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | R61MH129479 | Real time neurofeedback, its neurotransmitter underpinnings, and therapeutic effects, in clinical high risk individuals | 000 | 2 | NIH | 8/23/2024 | $1,217,224 |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | R01AG081809 | Sleep-dependent mechanisms of improving cerebral blood flow and reducing Alzheimer's disease progression by photobiomodulation with near-infrared light | 001 | 2 | NIH | 6/12/2024 | $71,515 |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | U01HG013781 | The VA Genomics Learning Health System: Implementing genomic medicine across diverse veteran communities | 000 | 1 | NIH | 9/23/2024 | $600,784 |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | R35HG010706 | Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care | 001 | 5 | NIH | 9/18/2024 | $255,000 |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 000 | 3 | NIH | 3/1/2024 | $303,224 |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 000 | 3 | NIH | 3/1/2024 | $100,000 |
| | 2024 | 2024 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01NS119227 | Neural Correlates of Sleep Homeostasis | 000 | 4 | NIH | 4/4/2024 | $314,038 |
| | 2024 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | R35HG010706 | Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care | 000 | 5 | NIH | 6/14/2024 | $0 |
| | 2024 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | R01HL126896 | A Novel Cognition-based Guidance System to Improve Surgical Safety | 001 | 7 | NIH | 2/9/2024 | $226,703 |
| | 2024 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R33MH113751 | Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients with Schizophrenia | 000 | 5 | NIH | 3/28/2024 | $0 |
| | 2024 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01DK114098 | Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications | 000 | 5 | NIH | 2/1/2024 | $0 |
| | 2024 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | R21MH125242 | Subcortical influence on the respiratory coordination of cortical neurodynamics related to cognition | 000 | 2 | NIH | 7/11/2024 | -$1,263 |
| | 2024 | 2019 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | RF1AG061774 | Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease | 000 | 2 | NIH | 1/6/2024 | $0 |
| | 2024 | 2019 | BOSTON VA RESEARCH INSTITUTE, INC. | 2 AVENUE DE LAFAYETTE | BOSTON | MA | 02111-1750 | SUFFOLK | USA | RF1AG061774 | Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease | 001 | 2 | NIH | 9/30/2024 | -$4,278 |
|
| Issue Date FY: 2023 ( Subtotal = $6,259,556 ) |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01HL126896 | A Novel Cognition-based Guidance System to Improve Surgical Safety | 001 | 7 | NIH | 8/28/2023 | $609,907 |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R35HG010706 | Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care | 003 | 5 | NIH | 7/6/2023 | $494,035 |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R33MH113751 | Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients with Schizophrenia | 000 | 5 | NIH | 6/22/2023 | $1,014,255 |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R35HG010706 | Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care | 002 | 4 | NIH | 12/8/2022 | $90,786 |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01NS119227 | Neural Correlates of Sleep Homeostasis | 002 | 3 | NIH | 4/7/2023 | $323,750 |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01AG081809 | Sleep-dependent mechanisms of improving cerebral blood flow and reducing Alzheimer's disease progression by photobiomodulation with near-infrared light | 000 | 1 | NIH | 5/4/2023 | $669,096 |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 000 | 2 | NIH | 3/1/2023 | $100,000 |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R61MH129479 | Real time neurofeedback, its neurotransmitter underpinnings, and therapeutic effects, in clinical high risk individuals | 000 | 1 | NIH | 8/17/2023 | $1,214,504 |
| | 2023 | 2023 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 000 | 2 | NIH | 3/1/2023 | $305,153 |
| | 2023 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R21MH125242 | Subcortical influence on the respiratory coordination of cortical neurodynamics related to cognition | 001 | 2 | NIH | 3/8/2023 | $36,292 |
| | 2023 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R33MH113751 | Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients with Schizophrenia | 002 | 4 | NIH | 7/26/2023 | $646,410 |
| | 2023 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01DK114098 | Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications | 002 | 5 | NIH | 12/7/2022 | $476,178 |
| | 2023 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R35HG010706 | Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care | 001 | 4 | NIH | 11/17/2022 | $97,082 |
| | 2023 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01NS119227 | Neural Correlates of Sleep Homeostasis | 001 | 2 | NIH | 1/18/2023 | $89,130 |
| | 2023 | 2019 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | RF1AG061774 | Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease | 001 | 2 | NIH | 5/3/2023 | $92,980 |
|
| Issue Date FY: 2022 ( Subtotal = $4,041,792 ) |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01DK114098 | Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications | 004 | 5 | NIH | 8/15/2022 | $252,243 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01DK114098 | Hemoglobin A1C Variability as a Risk Factor for Diabetes Complications | 003 | 5 | NIH | 8/12/2022 | $257,848 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R35HG010706 | Pragmatic randomized trial of polygenic risk scoring for common diseases in primary care | 001 | 4 | NIH | 8/12/2022 | $388,500 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01NS119227 | Neural Correlates of Sleep Homeostasis | 001 | 2 | NIH | 5/13/2022 | $323,750 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R21MH125242 | Subcortical influence on the respiratory coordination of cortical neurodynamics related to cognition | 001 | 2 | NIH | 8/29/2022 | $196,168 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R33MH113751 | Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients with Schizophrenia | 004 | 4 | NIH | 9/14/2022 | $1,029,505 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 002 | 1 | NIH | 5/5/2022 | -$100,000 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 002 | 1 | NIH | 5/5/2022 | $100,000 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 001 | 1 | NIH | 3/7/2022 | $0 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 001 | 1 | NIH | 3/7/2022 | $0 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 000 | 1 | NIH | 2/7/2022 | $100,000 |
| | 2022 | 2022 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | R01EY032510 | Developmental prosopagnosia subtypes: validation, neural mechanisms, and differential approaches to treatment | 000 | 1 | NIH | 2/7/2022 | $314,519 |
| | 2022 | 2019 | BOSTON VA RESEARCH INSTITUTE, INC. | 150 S HUNTINGTON AVE # 151B | BOSTON | MA | 02130-4817 | SUFFOLK | USA | RF1AG061774 | Slow-wave activity as a modifier of the progression of neurodegeneration in Alzheimer's disease | 002 | 2 | NIH | 7/21/2022 | $1,179,259 |
|
| Issue Date FY: 2016 ( Subtotal = $0 ) (Continued on the next page) |
|
